FAT1 c.6062G>A ;(p.R2021H)

Variant ID: 4-187541678-C-T

NM_005245.3(FAT1):c.6062G>A;(p.R2021H)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Case Report: Partial response to single-agent pembrolizumab in a chemotherapy-resistant metastatic pancreatic cancer patient with a high tumor mutation burden.

Frontiers In Oncology
Dai, Mengyao M; Sheng, Jianpeng J; Zhang, Qi Q; Wang, Jianxin J; Fu, Qihan Q; Liang, Tingbo T
Publication Date: 2023

Variant appearance in text: FAT1: R2021H
PubMed Link: 36937383
Variant Present in the following documents:
  • Main text
  • fonc-13-1118633.pdf
View BVdb publication page



Detection of Rare Germline Variants in the Genomes of Patients with B-Cell Neoplasms.

Cancers
Mosquera Orgueira, Adrián A; Cid López, Miguel M; Peleteiro Raíndo, Andrés A; Díaz Arias, José Ángel JÁ; Antelo Rodríguez, Beatriz B; Bao Pérez, Laura L; Alonso Vence, Natalia N; Bendaña López, Ángeles Á; Abuin Blanco, Aitor A; Melero Valentín, Paula P; Ferreiro Ferro, Roi R; Aliste Santos, Carlos C; Fraga Rodríguez, Máximo Francisco MF; González Pérez, Marta Sonia MS; Pérez Encinas, Manuel Mateo MM; Bello López, José Luis JL
Publication Date: 2021-03-16

Variant appearance in text: rs377498159
PubMed Link: 33809641
Variant Present in the following documents:
  • Main text
  • cancers-13-01340.pdf
View BVdb publication page